Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 15
2005 2
2006 5
2007 5
2008 4
2009 3
2010 4
2011 2
2012 7
2013 4
2014 5
2015 4
2016 7
2017 2
2018 3
2019 3
2020 2
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Results by year
Filters applied: . Clear all
Page 1
Evaluation of Vav3.1 as prognostic marker in endometrial cancer.
Boesch M, Sopper S, Marth C, Fiegl H, Wiedemair A, Rössler J, Hatina J, Wolf D, Reimer D, Zeimet AG. Boesch M, et al. Among authors: fiegl h. J Cancer Res Clin Oncol. 2018 Oct;144(10):2067-2076. doi: 10.1007/s00432-018-2725-2. Epub 2018 Aug 6. J Cancer Res Clin Oncol. 2018. PMID: 30083818 Free PMC article.
DNA hypomethylation is prevalent even in low-grade breast cancers.
Jackson K, Yu MC, Arakawa K, Fiala E, Youn B, Fiegl H, Müller-Holzner E, Widschwendter M, Ehrlich M. Jackson K, et al. Among authors: fiegl h. Cancer Biol Ther. 2004 Dec;3(12):1225-31. doi: 10.4161/cbt.3.12.1222. Epub 2004 Dec 9. Cancer Biol Ther. 2004. PMID: 15539937 Review.
High prevalence of side population in human cancer cell lines.
Boesch M, Zeimet AG, Fiegl H, Wolf B, Huber J, Klocker H, Gastl G, Sopper S, Wolf D. Boesch M, et al. Among authors: fiegl h. Oncoscience. 2016 Apr 10;3(3-4):85-87. doi: 10.18632/oncoscience.300. eCollection 2016. Oncoscience. 2016. PMID: 27226981 Free PMC article.
Evaluating L1CAM expression in human endometrial cancer using qRT-PCR.
Notaro S, Reimer D, Duggan-Peer M, Fiegl H, Wiedermair A, Rössler J, Altevogt P, Marth C, Zeimet AG. Notaro S, et al. Among authors: fiegl h. Oncotarget. 2016 Jun 28;7(26):40221-40232. doi: 10.18632/oncotarget.9574. Oncotarget. 2016. PMID: 27233077 Free PMC article.
75 results